EMA starts review of Russia Sputnik V jab


A woman receives the second component of the Gam-COVID-Vac (Sputnik V) COVID-19 vaccine.

Valentin Sprinchak | TASS | Getty Images

LONDON — The European Medicines Agency has said will start assessing the Russian coronavirus jab, Sputnik V, as the bloc looks to speed up its vaccination program.

“EMA will assess Sputnik V’s compliance with the usual EU standards for effectiveness, safety and quality. While EMA cannot predict the overall timelines, it should take less time than normal to evaluate an eventual application,” the regulator said in a statement on Thursday.

If the review is successful, the Russian vaccine would still need a marketing authorization application before being greenlit for administration across the 27 member states.

The news come after a number of European countries indicated that they could start administering Sputnik V, bypassing the regulator.

This is a breaking news story and it is being updated.



Source link

Discover

Sponsor

Latest

SPAC with ties to Biden Cabinet picks sees surge in Wall Street support

A company with ties to at least two people selected by Joe Biden for his Cabinet is seeing a surge in support from...

Money managers see profit-taking in Thursday’s ‘healthy pullback’

A trader works at his post on the floor of the New York Stock Exchange (NYSE) in New York.Brendan McDermid | ReutersThe high-flying...

2020 Chevrolet Corvette Suspension Deep Dive

I cannot recall a point during my automotive career – or even the college days that came before – that didn’t include some...

2021 Mercedes-Benz E 450 First Drive | What’s new for the updated E-Class sedan

Although the current generation of Mercedes-Benz E-Class launched in 2017, the luxury sedan has remained a class leader. And even Mercedes seems to...